Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review

Journal of Nutritional Biochemistry

Volumn 16, Issue 6, 2005, Pages 321-330

  Ricketts, Marie Louise ^a   Moore, David D ^a   Banz, William J ^b,c   Mezei, Orsolya ^d   Shay, Neil F ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Cholesterol; Isoflavone; Nuclear hormone receptors; Soy

Indexed keywords

CELL NUCLEUS RECEPTOR; CLOFIBRATE; DAIDZEIN; DEXAMETHASONE; EQUOL; ESTROGEN RECEPTOR; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GENISTEIN; GLYCITEIN; HORMONE RECEPTOR; ISOFLAVONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PREGNENOLONE; ROSIGLITAZONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

CLINICAL TRIAL; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPOLYSIS; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYTOCHEMISTRY; RECEPTOR BINDING; REVIEW;

ANIMALS; FEMALE; HUMANS; ISOFLAVONES; LIPID METABOLISM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHYTOESTROGENS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; SOYBEANS;

OVIS ARIES;

EID: 20144375350     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2004.11.008     Document Type: Review

References (66)

1. J.W. Anderson, B.M. Johnstone, and M.E. Cook-Newell Meta-analysis of the effects of soy protein intake on serum lipids N. Engl. J. Med. 333 1995 276 282
2. A.H. Lichtenstein Got soy? Am. J. Clin. Nutr. 73 2001 667 668
3. A.H. Lichtenstein Soy protein, isoflavones and cardiovascular disease risk J. Nutr. 128 1998 1589 1592
4. M.S. Anthony Soy and cardiovascular disease: cholesterol lowering and beyond J. Nutr. 130 2000 662S 663S
5. K.D. Setchell, N.M. Brown, and E. Lydeking-Olsen The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones J. Nutr. 132 12 2002 3577 3584
6. J.M. Obst, and R.F. Seamark Hormone studies on ewes grazing an oestrogenic (Yarloop clover) pasture during the reproductive cycle Aust. J. Biol. Sci. 28 3 1975 279 290
7. J. Yamakoshi, M.K. Piskula, T. Izumi, K. Tobe, M. Saito, and S. Kataoka Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits J. Nutr. 130 2000 1887 1893
8. M.R. Peluso, T.A. Winters, M.F. Shanahan, and W.J. Banz A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats J. Nutr. 130 2000 2333 2342
9. O. Mezei, C.N. Chou, K.J. Kennedy, C. Tovar-Palacio, and N.F. Shay Hepatic cytochrome P450-2A and phosphoribosylpyrophosphate synthetase-associated protein mRNAs are induced in the gerbil after consumption of isoflavone containing protein J. Nutr. 132 2002 2538 2544
10. J. Baum, H. Teng, J.W. Erdman, B.P. Klein, V.W. Persky, and S. Freels Long-term intake of soy protein lowers the risk of cardiovascular disease in postmenopausal women with high cholesterol Am. J. Clin. Nutr. 68 1998 545 561
11. E.A. Kirk, P. Sutherland, S.A. Wang, A. Chait, and R.C. LeBoeuf Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice J. Nutr. 128 6 1998 954 959
12. M.R. Adams, D.L. Golden, T.C. Register, M.S. Anthony, J.B. Hodgin, and N. Maeda The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha Arterioscler. Thromb. Vasc. Biol. 22 11 2002 1859 1864
13. M.R. Adams, D.L. Golden, M.S. Anthony, T.C. Register, and J.K. Williams The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins J. Nutr. 132 1 2002 43 49
14. A. Naaz, S. Yellayi, M.A. Zakroczymski, D. Bunick, D.R. Doerge, and D.B. Lubahn The soy isoflavone genistein decreases adipose deposition in mice Endocrinology 144 8 2003 3315 3320
15. S.J. Bhathena, and M.T. Velasquez Beneficial role of dietary phytoestrogens in obesity and diabetes Am. J. Clin. Nutr. 76 6 2002 1191 1201
16. V. Jayagopal, P. Albertazzi, E.S. Kilpatrick, E.M. Howarth, P.E. Jennings, and D.A. Hepburn Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes Diabetes Care 25 2002 1709 1714
17. J.W. Anderson, J.E. Blake, J. Turner, and B.M. Smith Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes Am. J. Clin. Nutr. 68 1998 1347S 1353S
18. V.A. Meshcheriakova, O.A. Plotnikova, K. Sharafetdinov, and T.A. Iatsyshina The use of the combined food products with soy protein in diet therapy for patients with diabetes mellitus type 2 Vopr. Pitan. 71 2002 19 24
19. D.J. Jenkins, C.W. Kendall, C.J. Jackson, P.W. Connelly, T. Parker, and D. Faulkner Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women Am. J. Clin. Nutr. 76 2002 365 372
20. M.L. Wheeler, S.E. Fineberg, N.S. Fineberg, R.G. Gibson, and L.L. Hackward Animal versus plant protein meals in individuals with type 2 diabetes and microalbuminuria: effects on renal, glycemic, and lipid parameters Diabetes Care 25 2002 1277 1282
21. K. Hermansen, M. Sondergaard, L. Hoie, M. Carstensen, and B. Brock Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects Diabetes Care 24 2001 228 233
22. J.J. Repa, S.D. Turley, J.A. Lobaccaro, J. Medina, L. Li, and K. Lustig Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers Science 289 5484 2000 1524 1529
23. M. Elisaf Effects of fibrates on serum metabolic parameters Curr. Med. Res. Opin. 18 5 2002 269 276
24. P. Walter, S. Green, G. Greene, A. Krust, J.M. Bornert, and J.M. Jeltsch Cloning of the human estrogen receptor cDNA Proc. Natl. Acad. Sci. U. S. A. 82 23 1985 7889 7893
25. P. Pace, J. Taylor, S. Suntharalingam, R.C. Coombes, and S. Ali Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha J. Biol. Chem. 272 41 1997 25832 25838
26. D. Kostelac, G. Rechkemmer, and K. Briviba Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element J. Agric. Food Chem. 51 26 2003 7632 7635
27. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, and P.T. van der Saag Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 10 1998 4252 4263
28. M. Casanova, L. You, K.W. Gaido, S. Archibeque-Engle, D.B. Janszen, and H.A. Heck Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro Toxicol. Sci. 51 2 1999 236 244
29. M. Axelson, J. Sjovall, B.E. Gustafsson, and K.D. Setchell Soya - a dietary source of the non-steroidal oestrogen equol in man and animals J. Endocrinol. 102 1 1984 49 56
30. C. Atkinson, S. Berman, O. Humbert, and J.W. Lampe In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production J. Nutr. 134 3 2004 596 599
31. F. Rafii, C. Davis, M. Park, T.M. Heinze, and R.D. Beger Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals Arch. Microbiol. 180 1 2003 11 16
32. L.B. Moore, B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, and T.M. Willson St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc. Natl. Acad. Sci. U. S. A. 97 13 2000 7500 7502
33. N.L. Urizar, A.B. Liverman, D.T. Dodds, F.V. Silva, P. Ordentlich, and Y. Yan A natural product that lowers cholesterol as an antagonist ligand for FXR Science 296 5573 2002 1703 1706
34. M. Makishima, T.T. Lu, W. Xie, G.K. Whitfield, H. Domoto, and R.M. Evans Vitamin D receptor as an intestinal bile acid sensor Science 296 5571 2002 1313 1316
35. V.W. Persky, M.E. Turyk, L. Wang, S. Freels, R. Chatterton Jr., and S. Barnes Effect of soy protein on endogenous hormones in postmenopausal women Am. J. Clin. Nutr. 75 1 2002 145 153 [erratum in: Am J Clin Nutr 2002 Sep;76(3):695]
36. L. Nagy, P. Tontonoz, J.G.A. Alvarez, H. Chen, and R.M. Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell 93 1998 229 240
37. G. Chinetti, S. Lestavel, V. Bocher, A.T. Remaley, B. Neve, and I.P. Torra PPARα and PPARγ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat. Med. 2001 53 58
38. J.G. DeLuca, T.W. Doebber, L.J. Kelly, R.K. Kemp, S. Molon-Noblot, and S.P. Sahoo Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice Mol. Pharmacol. 58 3 2000 470 476
39. A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J. Clin. Invest. 106 4 2000 523 531
40. T.E. Akiyama, S. Sakai, G. Lambert, C.J. Nicol, K. Matsusue, and S. Pimprale Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux Mol. Cell. Biol. 22 8 2002 2607 2619
41. O. Gavrilova, M. Haluzik, K. Matsusue, J.J. Cutson, L. Johnson, and K.R. Dietz Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass J. Biol. Chem. 278 36 2003 34268 34276
42. H. Kim, M. Haluzik, Z. Asghar, D. Yau, J.W. Joseph, and A.M. Fernandez Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis Diabetes 52 7 2003 1770 1778
43. Y. Lee, X. Yu, F. Gonzales, D.J. Mangelsdorf, M.Y. Wang, and C. Richardson PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue Proc. Natl. Acad. Sci. U. S. A. 99 18 2002 11848 11853
44. W.R. Oliver Jr., J.L. Shenk, M.R. Snaith, C.S. Russell, K.D. Plunket, and N.L. Bodkin A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport Proc. Natl. Acad. Sci. U. S. A. 98 9 2001 5306 5311
45. A. Chawla, C.H. Lee, Y. Barak, W. He, J. Rosenfeld, and D. Liao PPARdelta is a very low-density lipoprotein sensor in macrophages Proc. Natl. Acad. Sci. U. S. A. 100 3 2003 1268 1273
46. Y.X. Wang, C.H. Lee, S. Tiep, R.T. Yu, J. Ham, and H. Kang Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity Cell 113 2 2003 159 170
47. K.J. Moore, E.D. Rosen, M.L. Fitzgerald, F. Randow, L.P. Andersson, and D. Altshuler The role of PPAR-γ in macrophage differentiation and cholesterol uptake Nat. Med. 7 2001 41 47
48. G. Chinetti, J.-C. Fruchart, and B. Staels Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflamm. Res. 49 2000 497 505
49. A. Chawla, Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat. Med. 7 1 2001 48 52
50. S.A. Smith, C.A. Lister, C.D. Toseland, and R.E. Buckingham Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat Diabetes Obes. Metab. 2 2000 363 372
51. O. Mezei, W.J. Banz, R.W. Steger, M.R. Peluso, T.A. Winters, and N. Shay Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells J. Nutr. 133 2003 1238 1243
52. Z.C. Dang, V. Audinot, S.E. Papapoulos, J.A. Boutin, and C.W. Lowik PPARg as a molecular target for the soy phytoestrogen genistein J. Biol. Chem. 278 2003 962 967
53. G. Ferry, V. Bruneau, P. Beauverger, M. Goussard, M. Rodriguez, and V. Lamamy Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands Eur. J. Pharmacol. 417 1-2 2001 77 89
54. S. Barnes Evolution of the health benefits of soy isoflavones Proc. Soc. Exp. Biol. Med. 217 3 1998 386 392
55. H. Adlercreutz, and W. Mazur Phyto-oestrogens and Western diseases Ann. Med. 29 2 1997 95 120
56. K.D. Setchell Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones Am. J. Clin. Nutr. 68 6 Suppl 1998 1333S 1346S
57. M.J. Iqbal, S. Yaegashi, R. Ahsan, D.A. Lightfoot, and W.J. Banz Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate Physiol. Genomics 11 2002 219 226
58. W.J. Banz, N. Moustaind-Moussa, A. Tebbe, Y.-C. Kim, K.W. Cho, and N.F. Shay Soy diets regulate adiposity, insulin sensitivity and lipogenic capacity in male ZDF rats FASEB J. 2004 [(abs) 369.3.]
59. M. Suetsugi, L. Su, K. Karlsberg, Y.C. Yuan, and S. Chen Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors Mol. Cancer Res. 1 13 2003 981 991
60. J.D. Eudy, S. Yao, M.D. Weston, M. Ma-Edmonds, C.B. Talmadge, and J.J. Cheng Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41 Genomics 50 3 1998 382 384
61. H. Hong, L. Yang, and M.R. Stallcup Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3 J. Biol. Chem. 274 32 1999 22618 22626
62. N. Yang, H. Shigeta, H. Shi, and C.T. Teng Estrogen-related receptor, hER1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter J. Biol. Chem. 271 1996 5795 5804
63. R. Sladek, J.A. Bader, and V. Giguere The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme a dehydrogenase gene Mol. Cell. Biol. 17 9 1997 5400 5409
64. R.B. Vega, and D.P. Kelly A role for estrogen-related receptor alpha in the control of mitochondrial fatty acid beta-oxidation during brown adipocyte differentiation J. Biol. Chem. 272 50 1997 31693 31699
65. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, and N. Itoh Genistein, a specific inhibitor of tyrosine-specific protein kinases J. Biol. Chem. 262 12 1987 5592 5595
66. R. Paoletti, A. Corsini, and S. Bellosta Pharmacological interactions of statins Atherosclerosis 3 1 2002 35 40